Sort
82,697 grants matching “vaccine development”
PItt-Ohio State-Georgetown Clinical Trials Unit
$1,446,339John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2015 · AI
HIV Vaccine Research and Development â NIMH Division of AIDS Research
$1,445,717National Institute Of Allergy And Infectious Diseases · Y01 · FY2024 · AI
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
$1,445,380Stanley Perlman · University Of Iowa · P01 · FY2006 · AI
NIDA Clinical Trials Network: Greater New York Node
$1,445,101John P Rotrosen · New York University School Of Medicine · UG1 · FY2016 · DA
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
$1,443,819Stanley Perlman · University Of Iowa · P01 · FY2008 · AI
PPG: HOST VIRUS INTERACTIONS IN HCoV-SARS INFECTIONS
$1,443,818Stanley Perlman · University Of Iowa · P01 · FY2007 · AI
LITE CONNECT: Addressing testing gaps and epidemiologic disparities of COVID-19 amongtransgender people in the United States
$1,443,647Andrea L Wirtz · Johns Hopkins University · UH3 · FY2020 · AI
California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations
$1,443,116Joel Palefsky · University Of California, San Francisco · U54 · FY2019 · CA
Effects of Vaccination on Acute and Post-Acute Respiratory Viral Infection Outcomes in Solid Organ Transplant Recipients
$1,442,898William Werbel · Johns Hopkins University · R01 · FY2025 · AI
Monoclonal Antibody Therapy for West Nile Virus
$1,442,808Michael S. Diamond · Washington University · U01 · FY2006 · AI
Antiviral therapeutics for flavivirus infections
$1,442,798Chelsea Byrd Olsen · Siga Technologies, Inc. · R01 · FY2011 · AI
RESPIRATORY DISEASES CONTINUE TO BE A MAJOR CONCERN TO POULTRY PRODUCERS BECAUSE LOSSES INDUCED BY RESPIRATORY DISEASES HAVE SIGNIFICANT LOCAL AND NATIONAL ECONOMIC IMPACT TO THE INDUSTRY. PROTECTION OF POULTRY BY EFFECTIVE PREVENTION AND CONTROL OF DISEASES IS CRITICAL TO MAINTAIN WHOLESOME POULTRY PRODUCTS, WHICH IS THE NUMBER ONE ANIMAL PROTEIN CONSUMED IN THE U.S. SUCH EFFORTS MAKE A SIGNIFICANT CONTRIBUTION TOWARDS NATIONAL FOOD SECURITY. OUR GOAL IS TO DEVELOP KNOWLEDGE-BASED INTEGRATED APPROACHES TO DETECT, CONTROL AND PREVENT ENDEMIC, EMERGING AND RE-EMERGING POULTRY RESPIRATORY DISEASES IN THE U.S. IN THIS PROJECT, THE EFFORTS OF MULTIPLE INSTITUTIONS ACROSS THE COUNTRY WILL CONCENTRATE ON THE FOLLOWING FOUR SPECIFIC OBJECTIVES: 1) UNDERSTAND THE ECOLOGY OF POULTRY RESPIRATORY DISEASES; 2) INVESTIGATE THE MULTIFACTORIAL ETIOLOGY INVOLVING POULTRY RESPIRATORY DISEASES; 3) DEVELOP NEW AND IMPROVED DIAGNOSTIC TOOLS, VACCINES, AND NOVEL PREVENTIVE MEASURES; AND4) EDUCATE STAKEHOLDERS FOR PREVENTION AND CONTROL OF RESPIRATORY DISEASES.
$1,442,500Ohio State University, The · · FY2016 · National Institute of Food and Agriculture
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$1,442,278Judith S. Currier · University Of California Los Angeles · U01 · FY2011 · AI
Molecular Analysis of Tuberculosis Immunity
$1,442,274William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2009 · AI
Genetic Risk Variants in Atopic Dermatitis Associated with Eczema Herpeticum
$1,441,997Donald Ym Leung · National Jewish Health · U19 · FY2019 · AI
Discovery of new cellular targets for small-molecule inhibition of enveloped vir
$1,441,843Sean P. J. Whelan · Harvard Medical School · U19 · FY2016 · AI
Harvard Medical School Vaccine Clinical Trials Unit
$1,441,738Raphael Dolin · Harvard Medical School · U01 · FY2007 · AI
IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine Effectiveness
$1,441,647Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2021 · IP
US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$1,441,646Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2021 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$1,441,645Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2021 · IP
Exploring mechanisms that govern immune homeostasis in skin
$1,441,508Keisuke Nagao · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Coronavirus Challenge Core
$1,441,507Matthew Bryan Frieman · Washington University · P01 · FY2022 · AI
Research Capacity Core
$1,441,269Ming Bo Huang · Morehouse School Of Medicine · U54 · FY2023 · MD
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
$1,441,119Daniel Ernest Ford · Johns Hopkins University · UL1 · FY2011 · RR
New class of PBP inhibitors to address PBP2-mediated resistance in Neisseria gonorrhoeae
$1,441,089Denis Marc Daigle · Venatorx Pharmaceuticals, Inc. · R01 · FY2021 · AI